Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

IDXX Idexx Laboratories Earnings and EPS analysis

EPS in 2025 (TTM): $10.92

Last Report Period Date: Mar 31, 2025

According to the most recent financial data from March 2025, the current EPS (TTM) is $10.92. Idexx Laboratories's EPS for 2024 came in at $10.77, marking an increase from $10.17 in 2023. For the quarterly period ending on Mar 31, 2025, IDXX's EPS was $2.98.

IDXX earnings history

Historical annual and quarterly earnings per share (EPS) data for Idexx Laboratories
EPS (TTM)
$10.92
EPS Growth YoY (Quarterly)
4.9%
EPS (Quarterly)
$2.98
EPS Growth (Quarterly)
12.5%

Idexx Laboratories had an annual EPS of $10.77, marking an increase of 5.9% from $10.17 in 2023. The quarterly EPS for the period ending Mar 31, 2025, was $2.98, marking a 4.9% increase from the same quarter last year. IDXX's TTM EPS stands at $10.92 as of March 2025. Idexx Laboratories's EPS for 2023 stood at $10.17, a 25.2% increase from 2022.

IDXX EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
4.9%
EPS growth YoY
5.9%
EPS growth 3Y avg
7.2%
EPS growth 5Y avg
16.7%

Idexx Laboratories has recorded an increase in EPS of 4.9% over the last 12 months (YoY, quarterly). For the last three years, IDXX recorded an average annual EPS growth rate of 7.2%. Idexx Laboratories had an average annual EPS growth rate of 16.7% over the last 5 years. Across the last decade, IDXX had an average annual EPS growth of 19.5%.

IDXX Earnings Waterfall

Breakdown of revenue, profit and net income for Idexx Laboratories

IDXX Earnings vs Peers

What are the earnings of IDXX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
ABT Abbott Laboratories 17.31 133.8% 24.5% 29.9%
HSIC Henry Schein Inc 23 -3.5% -12% -8.2%
TMO Thermo Fisher Scientific Inc 25.2 6.8% -5.5% 12.4%
IDXX Idexx Laboratories Inc 49.55 5.9% 7.2% 16.7%
NEOG Neogen Corp N/A 66.7% N/A N/A
WOOF Petco Health & Wellness Company Inc N/A 92.3% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.